In this experimental study, the BH-treated core exhibited a higher liver fibrosis score (Fig. 2) and α-SMA expression (Fig. 3A) compared to both the BH-treated and BH-untreated lobes in the acute phase (7 days after BH treatment). This evidence concerns the gene ACTA1 and Hepatic fibrosis.